Gaynor JJ and Ciancio G |
The Importance of Using Serially Measured Tacrolimus Clearance Values, Especially During the Early Posttransplantation Period. |
2018 |
Transplantation |
pmid:29271869
|
Peterson LB et al. |
A tacrolimus-related immunosuppressant with biochemical properties distinct from those of tacrolimus. |
1998 |
Transplantation |
pmid:9448137
|
Shivaswamy V et al. |
Tacrolimus and sirolimus induce reproductive abnormalities in female rats. |
2011 |
Transplantation |
pmid:21508897
|
Silva HT et al. |
Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients. |
2014 |
Transplantation |
pmid:24521771
|
Rolles K et al. |
A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin. |
1999 |
Transplantation |
pmid:10551650
|
Nakamura Y et al. |
Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator. |
2003 |
Transplantation |
pmid:12717187
|
Pirsch JD |
Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group. |
1999 |
Transplantation |
pmid:10551653
|
Qi S et al. |
Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates. |
2003 |
Transplantation |
pmid:12717189
|
Calmus Y et al. |
Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients. |
2010 |
Transplantation |
pmid:20495510
|
Haririan A et al. |
Polyomavirus reactivation in native kidneys of pancreas alone allograft recipients. |
2003 |
Transplantation |
pmid:12717201
|
Egli A et al. |
Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs. |
2009 |
Transplantation |
pmid:19935369
|
Boyer O et al. |
Improvement of renal function in pediatric heart transplant recipients treated with low-dose calcineurin inhibitor and mycophenolate mofetil. |
2005 |
Transplantation |
pmid:15912111
|
Selzner N et al. |
Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome. |
2009 |
Transplantation |
pmid:19935376
|
Rush DN et al. |
Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetil. |
2009 |
Transplantation |
pmid:19935461
|
Numakura K et al. |
Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. |
2005 |
Transplantation |
pmid:16340785
|
Cendales LC et al. |
Composite tissue allotransplantation: development of a preclinical model in nonhuman primates. |
2005 |
Transplantation |
pmid:16340790
|
Mañez R et al. |
Fluconazole therapy in transplant recipients receiving FK506. |
1994 |
Transplantation |
pmid:7515201
|
Furukawa H et al. |
The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs. |
1992 |
Transplantation |
pmid:1373531
|
Sakr M et al. |
Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients. |
1992 |
Transplantation |
pmid:1373535
|
Hirano Y et al. |
Morphological and functional changes of islets of Langerhans in FK506-treated rats. |
1992 |
Transplantation |
pmid:1373536
|
Sindhi R et al. |
Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. |
2001 |
Transplantation |
pmid:11571449
|
Gupta A et al. |
Elevated myeloid: plasmacytoid dendritic cell ratio associates with late, but not early, liver rejection in children induced with rabbit anti-human thymocyte globulin. |
2009 |
Transplantation |
pmid:19696644
|
Gerlach UA et al. |
Intragraft and Systemic Immune Parameters Discriminating Between Rejection and Long-Term Graft Function in a Preclinical Model of Intestinal Transplantation. |
2017 |
Transplantation |
pmid:27607529
|
de Sandes-Freitas TV et al. |
Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus. |
2015 |
Transplantation |
pmid:25929604
|
First MR |
Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population. |
2001 |
Transplantation |
pmid:11585240
|
Sankary HN et al. |
FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. |
1998 |
Transplantation |
pmid:9798690
|
Koomans HA and Ligtenberg G |
Mechanisms and consequences of arterial hypertension after renal transplantation. |
2001 |
Transplantation |
pmid:11585243
|
Garcia-Criado FJ et al. |
Possible tacrolimus action mechanisms in its protector effects on ischemia-reperfusion injury. |
1998 |
Transplantation |
pmid:9798713
|
Tarumi K et al. |
CTLA4IgG treatment induces long-term acceptance of rat small bowel allografts. |
1999 |
Transplantation |
pmid:10071020
|
Mack-Shipman LR et al. |
Reproductive hormones after pancreas transplantation. |
2000 |
Transplantation |
pmid:11063337
|
Trimarchi HM et al. |
FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. |
1999 |
Transplantation |
pmid:10071024
|
Chisholm MA et al. |
Renal transplant patient compliance with free immunosuppressive medications. |
2000 |
Transplantation |
pmid:11063348
|
Pirsch JD et al. |
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. |
1997 |
Transplantation |
pmid:9112351
|
Sokal EM et al. |
Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. |
1997 |
Transplantation |
pmid:9392308
|
Rostaing L et al. |
Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. |
2005 |
Transplantation |
pmid:15818323
|
Baid-Agrawal S et al. |
Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients. |
2004 |
Transplantation |
pmid:15114085
|
Tzakis AG et al. |
Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. |
2004 |
Transplantation |
pmid:15114087
|
Lang T et al. |
Cholic acid synthesis is reduced in pediatric liver recipients during graft dysfunction due to ischemic injury and allograft rejection. |
1997 |
Transplantation |
pmid:9415561
|
Marino IR et al. |
Efficacy and safety of basiliximab with a tacrolimus-based regimen in liver transplant recipients. |
2004 |
Transplantation |
pmid:15385809
|
Talbot D et al. |
Alopecia as a consequence of tacrolimus therapy in renal transplantation? |
1997 |
Transplantation |
pmid:9415574
|
di Francesco F et al. |
One year follow-up of steroid-free immunosuppression plus everolimus in isolated pancreas transplantation. |
2008 |
Transplantation |
pmid:18946356
|
Aulagnon F et al. |
Diarrhea after kidney transplantation: a new look at a frequent symptom. |
2014 |
Transplantation |
pmid:25073040
|
Hadley S et al. |
Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. |
1995 |
Transplantation |
pmid:7535482
|
Alessiani M et al. |
Combined immunosuppressive therapy with tacrolimus and mycophenolate mofetil for small bowel transplantation in pigs. |
1996 |
Transplantation |
pmid:8830816
|
Gruessner RW and Sharp HL |
Living-related intestinal transplantation: first report of a standardized surgical technique. |
1997 |
Transplantation |
pmid:9415566
|
Abadja F et al. |
Impact of mycophenolic acid and tacrolimus on Th17-related immune response. |
2011 |
Transplantation |
pmid:21818055
|
Piao SG et al. |
Combined treatment of tacrolimus and everolimus increases oxidative stress by pharmacological interactions. |
2014 |
Transplantation |
pmid:24825522
|
Gujadhur A et al. |
CMV sinusitis in a HIV-negative renal transplant recipient. |
2014 |
Transplantation |
pmid:24827770
|
Shimada T et al. |
Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy. |
2002 |
Transplantation |
pmid:12451243
|
Riegersperger M et al. |
Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipients. |
2013 |
Transplantation |
pmid:23594858
|
Poncelet AJ et al. |
Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus. |
2008 |
Transplantation |
pmid:19077894
|
Uchida N et al. |
Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: a matched pair comparison with tacrolimus alone. |
2011 |
Transplantation |
pmid:21677598
|
Miyazawa H et al. |
Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion, and complement inhibition. |
1995 |
Transplantation |
pmid:7537396
|
Furlan V et al. |
Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients. |
1995 |
Transplantation |
pmid:7537398
|
Josephson MA et al. |
Treatment of renal allograft polyoma BK virus infection with leflunomide. |
2006 |
Transplantation |
pmid:16534472
|
McDiarmid SV et al. |
Factors affecting growth after pediatric liver transplantation. |
1999 |
Transplantation |
pmid:10030286
|
Shapiro R et al. |
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. |
1999 |
Transplantation |
pmid:10030287
|
Paty BW et al. |
Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. |
2002 |
Transplantation |
pmid:11884930
|
Dell'Antonio G and Randhawa PS |
"Striped" pattern of medullary ray fibrosis in allograft biopsies from kidney transplant recipients maintained on tacrolimus. |
1999 |
Transplantation |
pmid:10030300
|
Wu MJ et al. |
Lower variability of tacrolimus trough concentration after conversion from prograf to advagraf in stable kidney transplant recipients. |
2011 |
Transplantation |
pmid:21912349
|
Krook H et al. |
Immunosuppressive drugs in islet xenotransplantation: a tool for gaining further insights in the mechanisms of the rejection process. |
2002 |
Transplantation |
pmid:12438951
|
Nakata Y et al. |
Tacrolimus and myocardial hypertrophy. |
2000 |
Transplantation |
pmid:10830241
|
Baran DA et al. |
Tacrolimus in cardiac transplantation: efficacy and safety of a novel dosing protocol. |
2002 |
Transplantation |
pmid:12438960
|
Blaheta RA et al. |
Mycophenolate mofetil decreases endothelial prostaglandin E2 in response to allogeneic T cells or cytokines. |
2000 |
Transplantation |
pmid:10830246
|
van Maarseveen EM et al. |
Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot study. |
2013 |
Transplantation |
pmid:23250333
|
Ericzon BG et al. |
Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus. |
1997 |
Transplantation |
pmid:9000664
|
Schena FP et al. |
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. |
2009 |
Transplantation |
pmid:19155978
|
Kelly PA et al. |
Ciprofloxacin does not block the antiproliferative effect of tacrolimus. |
1997 |
Transplantation |
pmid:9000686
|
Gouraud A et al. |
Follow-up of tacrolimus breastfed babies. |
2012 |
Transplantation |
pmid:22996303
|
Ueda M et al. |
A proposal of FK506 optimal dosing in living related liver transplantations. |
1995 |
Transplantation |
pmid:7544035
|
Fisher A et al. |
FK506 hepatotoxicity in liver allograft recipients. |
1995 |
Transplantation |
pmid:7539961
|
MacDonald A |
Improving tolerability of immunosuppressive regimens. |
2001 |
Transplantation |
pmid:11833142
|
Mollevà DG et al. |
Heart and liver xenotransplantation under low-dose tacrolimus: graft survival after withdrawal of immunosuppression. |
2001 |
Transplantation |
pmid:11213062
|
Kim SJ et al. |
A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients. |
2006 |
Transplantation |
pmid:17038908
|
Paolillo JA et al. |
Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. |
2001 |
Transplantation |
pmid:11213069
|
Jain AB et al. |
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. |
2003 |
Transplantation |
pmid:14501862
|
Ogawa H et al. |
Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation. |
2002 |
Transplantation |
pmid:12151737
|
Deuse T et al. |
Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545. |
2012 |
Transplantation |
pmid:22971540
|
Jain A et al. |
One thousand consecutive primary liver transplants under tacrolimus immunosuppression: a 17- to 20-year longitudinal follow-up. |
2011 |
Transplantation |
pmid:21378604
|
Mathew A et al. |
Reversal of steroid-resistant rejection in renal allograft recipients using FK506. |
1995 |
Transplantation |
pmid:7482730
|
Fuchinoue S et al. |
Kidney transplantation after liver transplantation from the same donor: four cases of successful steroid withdrawal. |
2002 |
Transplantation |
pmid:11923698
|
Lauzurica R et al. |
Tacrolimus-associated severe bilateral corneal ulcer after renal transplantation. |
2002 |
Transplantation |
pmid:11923710
|
Peduto G et al. |
Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression. |
2000 |
Transplantation |
pmid:10919579
|
Younes BS et al. |
The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. |
2000 |
Transplantation |
pmid:10919581
|
Higgins RM et al. |
Conversion from tacrolimus to cyclosporin in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison. |
2000 |
Transplantation |
pmid:10919600
|
Cherikh WS et al. |
A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation. |
2003 |
Transplantation |
pmid:12923430
|
Zieliński A et al. |
Simultaneous pancreas-kidney transplant from living related donor: a single-center experience. |
2003 |
Transplantation |
pmid:12923442
|
Mendez R et al. |
A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. |
2005 |
Transplantation |
pmid:16082323
|
Mayer AD et al. |
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. |
1997 |
Transplantation |
pmid:9275110
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Tümgör G et al. |
A case of uneventful ABO-incompatible liver transplantation from a deceased donor managed with routine immunosuppressive treatment. |
2014 |
Turk J Gastroenterol |
pmid:25599790
|